Replies to post #389583 on Amarin Corp Plc (AMRN)

[Whalatane]

Ralphey… come on. Don’t dodge my question ….as a CVD patient on Repatha. Crestor and Vascepa.

Do U believe that Vascepa reduces CV event risk to a clinically significant degree ( more then 15 % RR )

Yes or No

If yes and your opinion is confirmed by RESPECT or MITIGATE….. some Co will find a way to sell Vascepa / Vazkepa in the EU sooner or later

But I digress
Yes or No
Does Vascepa lower CV event risk in the R-IT profile for CAD patients like myself ?
In your opinion
Yes or No
Thx

Kiwi

[Whalatane]

EV value is $136 m. ?
According to Yahoo F
EV is mkt cap - cash on hand .

So EV is $136m BUT they have how much inventory or hand .. $300m ?

I’ll let U do the math
Market values ( EV ) at $136m but U have $300m in inventory?

IF either RESPECT or MITIGATE confirm R-IT results to any CLINICALLY significant degree … expect activists to get activated

Kiwi

[Whalatane]

EV. Enterprise Value … but U probably know this
Kiwi